Home » Topics » BioWorld Science

BioWorld Science
RSS

AC Immune begins first-in-human study of ACI-12589 as diagnostic for Parkinson's disease

Feb. 10, 2021

VDA-1102 studied in new phase II trial for early forms of cutaneous T-cell lymphoma

Feb. 10, 2021

Basilea reports cohort 1 data from phase II study of derazantinib in intrahepatic cholangiocarcinoma

Feb. 10, 2021

Sotio ends phase I trial of ONCOS-102 with DCVAC/PCa in prostate cancer

Feb. 10, 2021

NeuroRx reports preliminary phase IIb/III trial data on Zyesami in COVID-19 respiratory failure

Feb. 10, 2021

Durvalumab data presented from SAFIR02-BREAST IMMUNO trial

Feb. 10, 2021

Glycosylation study casts new light on health and disease

Feb. 10, 2021

PaxMedica reports phase II data on PAX-101 for autism spectrum disorder

Feb. 10, 2021

Trefoil initiates phase II study of TTHX-1114 for Fuchs endothelial corneal dystrophy

Feb. 10, 2021

Phase III study of napabucasin in metastatic colorectal cancer misses primary endpoints

Feb. 10, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...